INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, cilt.18, sa.6, ss.671-675, 2014 (SCI-Expanded)
BACKGROUND: The antimicrobial peptide cathelicidin LL-37/hCAP-18 and human beta-defensins (hBD) are key factors in innate immune responses of the respiratory tract.